高级检索

芍药苷调控JAK/STAT3通路干预HepG2细胞PD-L1表达的研究

Paeoniflorin inhibits programmed cell death-1-ligand 1 expression in HepG2 cells by regulating JAK/STAT3 signal pathway

  • 摘要: 为探究芍药苷对程序性死亡受体-配体1(programmed cell death-Ligand 1,PD-L1)表达的影响及作用机制,研究采用干扰素γ(IFN-γ)诱导HepG2细胞建立体外PD-L1高表达细胞模型。采用MTT法检测芍药苷的细胞毒性,通过流式细胞术、ELISA、RT-PCR法检测其对PD-L1蛋白和mRNA表达的影响;建立HepG2细胞和Jurkat T细胞共培养体系,ELISA检测芍药苷干预后共培养24 h后的IL-2的表达,CCK-8法检测药物干预后T细胞增殖情况,Western blot检测芍药苷作用后HepG2细胞中PD-L1、Janus激酶(Janus kinase,JAK)和信号传导及转录激活因子(signal transducers and activators of transcription,STAT3)的蛋白表达。实验结果表明,芍药苷能够显著下调PD-L1蛋白和mRNA的表达水平,增加共培养体系中的IL-2的浓度,促进T细胞显著增殖,此外,芍药苷能显著抑制JAK和STAT3的蛋白磷酸化。实验结果表明,芍药苷能够下调PD-L1的表达,其机制可能与JAK/STAT3通路有关。

     

    Abstract: In order to explore the effect and its mechanism of paeoniflorin on PD-L1, a PD-L1 high expression cell model was established in interferon gamma(IFN-γ)-induced HepG2 cells. The cytotoxicity of paeoniflorin was detected by MTT assay. Flow cytometry, ELISA and RT-PCR were performed to detect protein and mRNA levels of PD-L1 regulated by paeoniflorin. In HepG2 cells and Jurkat T cell co-culture system, the expression of IL-2 was detected by ELISA. Besides, T cell proliferation was evaluated by CCK-8 method, and the protein expression levels of PD-L1, JAK and STAT3 after drug treatment were determined by Western blot. These results indicated that paeoniflorin could significantly down-regulate the levels of PD-L1 protein and mRNA. In addition, it increased the number of T cells and the concentration of IL-2 in the co-culture system. Furthermore, paeoniflorin could significantly inhibit the protein expression of JAK and STAT3. Au the above experimental data indicated that paeoniflorin could down-regulate the expression of PD-L1, and its mechanism might be related to the JAK/STAT3 pathway.

     

/

返回文章
返回